USP <161> Testing for Medical Devices

Medical Devices Testing

Bacterial endotoxin testing is an important component of medical device quality control, particularly for devices that come into contact with the cardiovascular system, lymphatic system, or cerebrospinal fluid. USP <161>, Medical Devices—Bacterial Endotoxin and Pyrogen Tests, provides guidance for evaluating bacterial endotoxins and pyrogens associated with medical devices.

BA Sciences provides bacterial endotoxin testing services to help medical device manufacturers evaluate endotoxin contamination and support applicable regulatory and product quality requirements. Our microbiology team works with clients to establish appropriate testing approaches based on device characteristics, intended use, and applicable specifications.

What Is USP <161> Testing?

USP <161> addresses bacterial endotoxin and pyrogen testing considerations for medical devices. Bacterial endotoxins are lipopolysaccharides (LPS) associated with the outer membranes of Gram-negative bacteria.

When introduced into the body, endotoxins can trigger inflammatory responses, including fever and potentially serious adverse reactions. Because endotoxins may remain present even after bacteria have been killed or removed, sterilization alone does not necessarily ensure acceptable endotoxin levels.

Bacterial endotoxin testing helps manufacturers evaluate endotoxin contamination and determine whether devices meet applicable acceptance criteria.

Contact Us

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
Name*
Company Address*

Which Medical Devices May Require Endotoxin Testing?

Medical devices that directly or indirectly contact certain body systems may require bacterial endotoxin testing based on their intended use, patient exposure, and applicable regulatory requirements.

Examples include:

  • Infusion and transfusion equipment
  • Dialysis tubing and components
  • Vascular implants
  • Intravascular catheters
  • Certain surgical instruments
  • Devices contacting cerebrospinal fluid

Certain ophthalmic devices Endotoxin contamination may be introduced through manufacturing water, raw materials, equipment, handling practices, or microbial biofilms.

Unlike viable microorganisms, bacterial endotoxins are not necessarily eliminated by conventional sterilization processes. Appropriate contamination controls and endotoxin testing help manufacturers evaluate potential risks throughout production.

Understanding USP <161> Limits for Medical Devices

Bacterial endotoxin acceptance limits depend on the device’s intended use, the type of patient contact, and applicable regulatory requirements.

FDA guidance identifies commonly applied limits for certain medical device categories:

  • Cardiovascular and Lymphatic Contact: 20 endotoxin units (EU) per device or 0.5 EU/mL of extract under specified extraction conditions.

Cerebrospinal Fluid Contact: 2.15 EU/device or 0.06 EU/mL of extract under specified extraction conditions. Devices intended for intraocular use may have different, more stringent requirements.

These values are not universal limits for all medical devices. Appropriate acceptance criteria must consider the device’s intended use, extraction conditions, applicable standards, and regulatory expectations.

Working with an experienced analytical testing laboratory can help manufacturers select suitable methods and evaluate results against the appropriate specifications.

Bacterial Endotoxin Testing Methods for Medical Devices

Bacterial endotoxin testing is commonly performed using Limulus amebocyte lysate (LAL) assays, which detect endotoxin through an enzyme-mediated reaction.

USP <85>, Bacterial Endotoxins Test, describes established LAL testing techniques, including gel-clot, turbidimetric, and chromogenic methods.

BA Sciences offers bacterial endotoxin testing approaches, including:

  • Gel-Clot LAL Testing: Detects endotoxin through clot formation at a defined reagent sensitivity and can be used for qualitative limit testing or semiquantitative analysis.
  • Endpoint Chromogenic Testing: Measures color development produced by an endotoxin-triggered enzymatic reaction to determine endotoxin activity.

Kinetic Chromogenic Testing: Monitors color development over time to quantify endotoxin activity in a sample. Selecting the appropriate method depends on the medical device, sample characteristics, required sensitivity, and potential assay interference.

Method suitability testing is important to demonstrate that the sample does not inhibit or enhance the assay response.

Preparing Samples for Endotoxin Testing

Proper sample preparation is essential for obtaining reliable bacterial endotoxin testing results.

Medical devices may require extraction procedures to recover endotoxins from relevant surfaces or internal pathways. Depending on the device, preparation may involve immersion, rinsing, or flushing with water suitable for bacterial endotoxin testing.

The appropriate extraction procedure depends on several factors, including:

  • Device materials and surface characteristics
  • Size, geometry, and internal fluid pathways
  • Intended patient contact
  • Extraction conditions and sample volume
  • Potential interference with the endotoxin assay

Extraction procedures should be selected and justified based on applicable standards and the characteristics of the device.

Working with a qualified testing laboratory helps ensure that sample preparation and analytical methods are appropriate for the intended application.

How BA Sciences Supports Medical Device Endotoxin Testing

BA Sciences provides microbiological testing services to support medical device manufacturers throughout product development and quality control.

Our bacterial endotoxin testing capabilities help clients evaluate endotoxin contamination using appropriate analytical methods and established testing procedures.

With experienced scientific personnel and dedicated project management, BA Sciences emphasizes clear communication, reliable testing, and responsive technical support.

Our team works with clients to understand device-specific requirements, coordinate sample preparation, and establish testing strategies aligned with applicable quality and regulatory expectations.

Explore our microbiological testing services or contact BA Sciences to discuss your project requirements.

Ready to get started? Tell us about your upcoming project

Tell Us About Your Project